Radiation and Free Radical
- Institution
- University of Iowa, IA
- Principal investigator
- Douglas Robert Spitz
- Funding
- $125K
- Duration
- 2000–2026
Moonbase score
Still being scored
Abstract
The Radiation Free Radical Research Core (RFRRC) facilitates Holden Comprehensive Cancer Center (HCCC) researcher investigations that require radiation services or quantitative methods for analyzing and manipulating redox status and redox based biological changes. It serves both HCCC members and cancer researchers at other institutions. The RFRRC has been in operation since 1947, and is directed by Douglas Spitz, PhD; Frederick Domann, Jr, PhD; Garry Buettner, PhD; and Prabhat Goswami, PhD all of whom have extensive experience and international reputations in free radical-focused cancer research. The RFRRC provides three basic services. Ionizing radiation services are supplemented by phosphorimaging and cell-cycle analytical tools critical to understanding basic cellular behavior and responses to radiation and chemotherapy. Electron paramagnetic resonance spectroscopy and other analytical chemistry detection methodologies are available for measuring free radicals, singlet oxygen, small molecule antioxidants, nitric oxide and the array of related oxidants and oxidative damage products. Antioxidant enzyme services provide easy access to technologies for modifying and measuring molecules responsible for pro-oxidant formation and oxidative damage. Major equipment available in the RFRRC includes several radiation sources, a Seahorse analyzer, various types of spectrophotometers, hypoxia chambers, and equipment for HPLC separation and analyte detection. The RFRRC provides HCCC members with easy access to specialized knowledge, reagents, equipment and resources in a highly collaborative and helpful environment.
LOADING MOONBASE SCORE
Questions for University of Iowa
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of IowaNot yet scored
Project 2: Targeting CXCR4 and Redox Metabolism for Targeted Alpha Therapy of Pulmonary Neuroendocrine Tumors and Carcinomas
Douglas Robert Spitz · $404K · 2025–2030
- NIH · University of IowaNot yet scored
Free Radical Metabolism and Imaging
Douglas Robert Spitz · $125K · 2000–2026
- NIH · University of Iowa67
Airborne PCBs and Their Metabolites: Risk Factors for Adverse Neurodevelopmental Outcomes in Adolescence
Hans-Joachim Lehmler · $319K · 2006–2030